Technical Analysis for VCNX - Vaccinex, Inc.

Grade Last Price % Change Price Change
grade C 6.35 1.60% 0.10
VCNX closed up 1.6 percent on Wednesday, April 24, 2019, on 1.12 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Up
See historical VCNX trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Crossed Above 20 DMA Bullish 1.60%
Stochastic Buy Signal Bullish 1.60%
Wide Bands Range Expansion 1.60%
Oversold Stochastic Weakness 1.60%
Narrow Range Bar Range Contraction 15.45%
NR7 Range Contraction 15.45%

Older signals for VCNX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Vaccinex Inc. is a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics. The Company is focused on providing treatments for serious diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It provides SEMA4D antibody platform, which is focused on developing its lead product candidate VX15/2503 (VX15) for the treatment of non-small cell lung cancer, NSCLC, osteosarcoma, melanoma and Huntington’s disease. It also provides ActiveMAb antibody discovery platform, a human antibody discovery platform used for expressing large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface of vaccinia, a mammalian virus. Its product candidate VX5 is in preclinical development for the treatment of multiple sclerosis and potentially for other autoimmune disorders.
Health Biotechnology Cancer Biology Immunology Antibodies Immune System Monoclonal Antibodies Non Small Cell Lung Cancer Multiple Sclerosis Antibody Melanoma Serious Diseases Autoimmune Disorders Neurodegenerative Diseases Treatment Of Non Small Cell Lung Cancer Osteosarcoma Treatment Of Multiple Sclerosis Nsclc Seth Lederman Tolerx
Is VCNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.0
52 Week Low 3.32
Average Volume 15,779
200-Day Moving Average 0.0
50-Day Moving Average 5.1968
20-Day Moving Average 6.2757
10-Day Moving Average 6.031
Average True Range 0.8228
ADX 30.77
+DI 24.3329
-DI 15.0546
Chandelier Exit (Long, 3 ATRs ) 5.5316
Chandelier Exit (Short, 3 ATRs ) 7.2184
Upper Bollinger Band 7.93
Lower Bollinger Band 4.6214
Percent B (%b) 0.52
BandWidth 52.720812
MACD Line 0.1976
MACD Signal Line 0.3211
MACD Histogram -0.1235
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.13
Resistance 3 (R3) 7.12 6.85 7.00
Resistance 2 (R2) 6.85 6.65 6.86 6.96
Resistance 1 (R1) 6.60 6.53 6.73 6.61 6.91
Pivot Point 6.33 6.33 6.39 6.34 6.33
Support 1 (S1) 6.08 6.13 6.21 6.09 5.79
Support 2 (S2) 5.81 6.01 5.82 5.74
Support 3 (S3) 5.56 5.81 5.70
Support 4 (S4) 5.57